Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
-
-
-
-
-
-
-
OKYO Pharma chairman increases stake with 82,018 share purchase
-
-
-
-
-
-
-
OKYO Pharma (OKYO) Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
-
-
-
-
-
-
-
Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited
-
-
-
-
-
-
-
OKYO Pharma (OKYO) Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
-
-
-
-
-
-
-
OKYO Pharma (OKYO) Granted European Patent for OK-101
-
-
-
-
424,151 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

